A case-control study by Togha et al found that individuals who eventually developed CM had significantly higher baseline IL-6, TNF-α, and CRP compared to those who remained episodic, further implicating systemic inflammation in migraine progression[10]. The gene discussed is IL6; the disease is migraine disorder.